20 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

• GNC Holdings, Inc. GNC stock rose 58.56% to $0.97 during Thursday's pre-market session.

• Kitov Pharma, Inc. KTOV stock moved upwards by 20.51% to $1.04.

• Sorrento Therapeutics, Inc. SRNE stock rose 14.93% to $6.39. The most recent rating by Dawson James, on May 26, is at Buy, with a price target of $24.

• Inovio Pharmaceuticals, Inc. INO stock moved upwards by 9.89% to $26.23. The most recent rating by Benchmark, on May 21, is at Buy, with a price target of $28.

• Rite Aid, Inc. RAD shares rose 7.08% to $13.77. The most recent rating by Deutsche Bank, on Apr 17, is at Hold, with a price target of $12.

• Athersys, Inc. ATHX shares rose 6.31% to $2.36. The most recent rating by Needham, on May 8, is at Buy, with a price target of $5.

• ADMA Biologics, Inc. ADMA shares moved upwards by 5.96% to $3.02. The most recent rating by Oppenheimer, on May 7, is at Outperform, with a price target of $7.

• Novavax, Inc. NVAX stock moved upwards by 5.68% to $81.90. The most recent rating by Cantor Fitzgerald, on Jun 19, is at Overweight, with a price target of $88.

• Aethlon Medical, Inc. AEMD shares rose 4.89% to $2.36.

• Citius Pharmaceuticals, Inc. CTXR shares moved upwards by 4.60% to $0.91.

Losers

• uniQure, Inc. QURE shares fell 17.02% to $52.20 during Thursday's pre-market session. The most recent rating by Wells Fargo, on Jun 25, is at Equal-Weight, with a price target of $56.

• Magenta Therapeutics, Inc. MGTA stock declined 12.93% to $8.42. The most recent rating by Goldman Sachs, on Jun 8, is at Buy, with a price target of $15.

• SINTX Technologies, Inc. SINT stock declined 9.52% to $1.90.

• Ra Medical Systems, Inc. RMED shares fell 8.87% to $0.50. The most recent rating by Piper Sandler, on May 14, is at Neutral, with a price target of $1.

• NantKwest, Inc. NK stock decreased by 8.15% to $11.15.

• Translate Bio, Inc. TBIO shares decreased by 7.61% to $24.63.

• Titan Pharmaceuticals, Inc. TTNP stock declined 7.27% to $0.38.

• HTG Molecular Diagnostics, Inc. HTGM stock declined 6.10% to $0.74. The most recent rating by HC Wainwright & Co., on May 14, is at Buy, with a price target of $1.

• Twist Bioscience, Inc. TWST stock fell 5.64% to $39.

• Genetic Technologies, Inc. GENE stock decreased by 5.16% to $2.02.